TEACHERS ADVISORS, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q1 2019$9,307,000
+16.0%
134,190
-27.3%
0.01%0.0%
Q4 2018$8,023,000
-71.1%
184,516
-49.3%
0.01%
-35.3%
Q3 2018$27,774,000
+35.9%
363,820
+36.9%
0.02%
-34.6%
Q2 2018$20,431,000
+56.2%
265,788
+3.6%
0.03%
+52.9%
Q1 2018$13,082,000
+49.0%
256,551
+35.5%
0.02%
+54.5%
Q4 2017$8,779,000
-2.9%
189,275
+11.5%
0.01%
-8.3%
Q3 2017$9,044,000
-14.3%
169,817
-0.0%
0.01%
-20.0%
Q2 2017$10,552,000
-5.0%
169,886
+3.7%
0.02%
-6.2%
Q1 2017$11,109,000
-0.4%
163,898
+3.3%
0.02%
-11.1%
Q4 2016$11,158,000
-9.2%
158,695
-8.4%
0.02%
-10.0%
Q3 2016$12,291,000
+45.5%
173,265
+0.3%
0.02%
+33.3%
Q2 2016$8,449,000
-18.8%
172,755
+5.1%
0.02%
-21.1%
Q1 2016$10,411,000
-31.9%
164,447
+20.7%
0.02%
-34.5%
Q4 2015$15,279,000
+50.6%
136,198
+29.3%
0.03%
+45.0%
Q3 2015$10,145,000
+88.8%
105,332
+100.7%
0.02%
+100.0%
Q2 2015$5,373,000
+739.5%
52,476
+409.1%
0.01%
+900.0%
Q1 2015$640,000
+55.3%
10,307
+9.9%
0.00%0.0%
Q4 2014$412,000
-22.4%
9,3800.0%0.00%0.0%
Q3 2014$531,000
+26.1%
9,3800.0%0.00%0.0%
Q2 2014$421,000
-11.0%
9,380
-3.1%
0.00%0.0%
Q1 2014$473,0009,6800.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2019
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders